CLINICAL_TRIALS
trial_result
· 2017-07-21
Clinical Trial Update: Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia [Phase 3]
Summary
A Phase 3 trial evaluating the efficacy and safety of UI05MSP015CT for functional dyspepsia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Korea United Pharm. Inc. | Conditions: Functional Dyspepsia | Phase 3 | Status: COMPLETED